Patents by Inventor Salman Ashraf

Salman Ashraf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6962785
    Abstract: A method of screening for compounds useful for inhibiting retrovirus propagation in a host for the retrovirus, wherein the retrovirus primes reverse transcription in the host by binding of a specific host tRNA to retrovirus RNA at at least a pair of separate binding sites on the host tRNA, comprises contacting the specific host tRNA to the retrovirus RNA in the presence of the test compound, and then determining whether the compound inhibits the binding of the specific host tRNA to the retrovirus RNA in the presence of the test compound.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: November 8, 2005
    Assignee: North Carolina State University
    Inventors: Paul F. Agris, Salman Ashraf
  • Publication number: 20030008808
    Abstract: Methods of inhibiting microbial and viral propagation, and screening for compounds that inhibit microbial and viral propagation, are described. A method of inhibiting microbial propagation comprises inhibiting ribosomal binding of a specific microbial tRNA in the microbe by an amount sufficient to inhibit microbe propagation. A method of inhibiting retrovirus propagation in a host for that retrovirus, wherein that retrovirus primes reverse transcription by binding of a specific host tRNA to retrovirus RNA at at least a pair of separate binding sites on the host tRNA, comprises inhibiting the binding of the specific host tRNA to the retrovirus RNA at one of the binding sites by an amount sufficient to inhibit propagation of the retrovirus in the host.
    Type: Application
    Filed: August 6, 2002
    Publication date: January 9, 2003
    Inventors: Paul F. Agris, Salman Ashraf
  • Patent number: 6461815
    Abstract: Methods of inhibiting microbial propagation, and screening for compounds that inhibit microbial propagation, are described. A method of inhibiting microbial propagation comprises inhibiting ribosomal binding of a specific microbial tRNA in the microbe by an amount sufficient to inhibit microbe propagation. A method of screening for compounds useful for inhibiting microbial propagation comprises contacting a specific microbial tRNA to a ribosome that binds that tRNA in the presence of the test compound, and then determining whether the compound inhibits the binding of that tRNA.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: October 8, 2002
    Assignee: North Carolina State University
    Inventors: Paul F. Agris, Salman Ashraf
  • Patent number: 5545328
    Abstract: A preselected hemoglobin species is separated from contaminants having a different acidity from that of the preselected hemoglobin species, by an overload displacement chromatography process. To remove more acidic contaminants, the process is conducted under anion exchange conditions. To remove more basic contaminants, the process is conducted under cation exchange conditions. In either case, the exchange column is overloaded to displace the hemoglobin species therefrom with contaminants having greater affinity for the column, and using the impure hemoglobin solution as the displacer.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: August 13, 1996
    Assignee: Hemosol Inc.
    Inventors: Diana H. Pliura, Diane E. Wiffen, Salman Ashraf, Anthony A. Magnin
  • Patent number: 5439591
    Abstract: Hemoglobin is purified from a crude solution thereof, to obtain an aqueous solution containing at least 99% of a preselected hemoglobin species, by a two stage displacement chromatography process. One of the stages is conducted under anionic exchange conditions, and the other under cationic exchange conditions. In both stages, the exchange column is overloaded to displace the hemoglobin species therefrom with contaminants having greater affinity for the column, and using the impure hemoglobin solution as the displacer. Normally, anionic exchange is conducted first, with contaminants more acidic than the hemoglobin displacing the hemoglobin from the column and themselves remaining attached to the column for separation. The cationic exchange process is conducted second, on the eluent from the first column, and in this stage, the more basic contaminants displace the hemoglobin from the column under overload conditions, to yield a substantially pure hemoglobin solution.
    Type: Grant
    Filed: January 27, 1994
    Date of Patent: August 8, 1995
    Assignee: Hemosol Inc.
    Inventors: Diana Pliura, Diane Wiffen, Salman Ashraf, Anthony Magnin